title: AIDS vaccine therapy: phase I trial.
authors.forename: O
authors.initials: O
authors.lastname: Picard
authors.forename: P
authors.initials: P
authors.lastname: Giral
authors.forename: M C
authors.initials: MC
authors.lastname: Defer
authors.forename: M
authors.initials: M
authors.lastname: Fouchard
authors.forename: M
authors.initials: M
authors.lastname: Morel
authors.forename: M C
authors.initials: MC
authors.lastname: Meyohas
authors.forename: J
authors.initials: J
authors.lastname: Lebas
authors.forename: J C
authors.initials: JC
authors.lastname: Imbert
authors.forename: J
authors.initials: J
authors.lastname: Frottier
authors.forename: J J
authors.initials: JJ
authors.lastname: Salaun
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D004341:Drug Evaluation; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D016032:Randomized Controlled Trials as Topic; D014612:Vaccines / Q000008:administration & dosage*; D015164:Vaccines, Inactivated / Q000008:administration & dosage*; D014614:Vaccines, Synthetic / Q000008:administration & dosage*; D014765:Viral Vaccines / Q000008:administration & dosage*
chemical_list: D014612:Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines